Vertex Pharmaceuticals is a biotechnology company based in Boston, Massachusetts. Founded in 1989, it focuses on developing innovative therapies for serious diseases, particularly those caused by genetic mutations. The company is well-known for its work in treating cystic fibrosis, a genetic disorder that affects the lungs and digestive system. Vertex has made significant advancements in cystic fibrosis treatment through its portfolio of drugs that target the underlying causes of the disease. These therapies have improved the quality of life for many patients and have positioned Vertex as a leader in the biotechnology industry.